Post-Kidney Transplant Neutropenia After Alemtuzumab Induction: Risk Factors and Graft Outcomes.

被引：0
|
作者：
Zachariah, M. [1 ,2 ]
Fallahzadeh, M. [3 ]
Gumber, R. [1 ,2 ]
Kumar, A. [3 ]
Patel, S. [1 ,2 ]
Sharma, R. [1 ,2 ]
Singh, N. [3 ]
Gudleski, G. [1 ,2 ]
Venuto, R. [1 ,2 ]
机构：
[1] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA
[3] LSUHSC Shreveport, Dept Internal Med, Shreveport, LA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C1805
引用
收藏
页码：582 / 582
页数：1
相关论文
共 50 条
  • [41] Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients
    Ge, Shili
    Karasyov, Artur
    Sinha, Aditi
    Petrosyan, Anna
    Lovato, Darly
    Thomas, David L.
    Vo, Ashley
    Jordan, Stan C.
    Toyoda, Mieko
    TRANSPLANTATION, 2017, 101 (07) : 1720 - 1726
  • [42] Cannabis Dependence or Abuse before and after Kidney Transplantation: Implications for Post-Transplant Outcomes.
    Lentine, K.
    Alhamad, T.
    Lam, N.
    Naik, A.
    Koraishy, F.
    Randall, H.
    Segev, D.
    Dharnidharka, V.
    Brennan, D.
    Kasiske, B.
    Ouseph, R.
    Schnitzler, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 294 - 294
  • [43] Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes.
    Gibney, E.
    Ommert, T.
    Cross, R.
    Ray, A.
    Lizcano, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 330
  • [44] SCREENING FOR DE NOVO DSA POST-KIDNEY TRANSPLANT IN PATIENTS WITH NORMAL GRAFT FUNCTION
    Nickerson, Peter
    Gibson, Ian
    Pochinco, Denise
    Kelm, Dawn
    Hacking, Kendra
    Blydt-Hansen, Tom
    Rush, David
    HUMAN IMMUNOLOGY, 2009, 70 : S63 - S63
  • [45] Post-kidney transplant body mass index trajectories are associated with graft loss and mortality
    Liu, Yi
    Bendersky, Victoria A.
    Chen, Xiaomeng
    Ghildayal, Nidhi
    Harhay, Meera N.
    Segev, Dorry L.
    McAdams-DeMarco, Mara
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [46] LONG-TERM OUTCOMES OF INDUCTION THERAPIES WITH ALEMTUZUMAB, BASILIXIMAB OR METHYLPREDNISOLONE IN KIDNEY TRANSPLANT PATIENTS WITH DELAYED GRAFT FUNCTION
    Zhang, A.
    Teran, F.
    Zhang, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 640 - 640
  • [47] Characteristics, risk factors, and outcomes of neutropenia after liver or kidney transplantation in children
    Jarasvaraparn, Chaowapong
    Choudhury, Shelley
    Rusch, Courtney
    Nadler, Michelle
    Liss, Kim H. H.
    Stoll, Janis
    Hmiel, Stanley
    Khan, Adeel
    Doyle, Maria
    Kulkarni, Sakil
    PEDIATRIC TRANSPLANTATION, 2022, 26 (01)
  • [48] Composite Scores to Predict Post-Kidney Transplant Outcomes for Older Donors.
    Maluf, D.
    Jae, L.
    Suh, L.
    Anne, K.
    Pasha, D.
    Lorenzo, G.
    Kenneth, B.
    Valeria, M.
    TRANSPLANTATION, 2014, 98 : 596 - 596
  • [49] Post-Transplant Lymphoproliferative Disorder Following Alemtuzumab Induction in Kidney Transplantation
    Tenbrink, Patrick
    Wu, Jinling
    Zaremba, Cassandra
    Jordan, Matthew
    Rees, Michael
    Ortiz, Jorge
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 50 - 50
  • [50] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS FOLLOWING ALEMTUZUMAB INDUCTION IN KIDNEY TRANSPLANTATION
    Sawhney, Harpreet
    Charif, Rawya
    Galliford, Jack
    McLean, Adam
    Taube, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
12345